文献速递脑血管病外科神经重症

南非夸祖鲁-纳塔尔省专科医院动脉瘤性蛛网膜下腔出血血管内治疗的长期结局

Endovascular Management and Long-Term Outcomes of Aneurysmal Subarachnoid Hemorrhage Among a Large Cohort of Patients Managed at a Specialist Hospital in KwaZulu-Natal, South Africa from 2012 to 2021.
PubMed 文献 · World Neurosurg · 2025-08-14

该回顾性研究分析了2012至2021年间在南非一家四级医院接受血管内治疗的445例动脉瘤性蛛网膜下腔出血患者。出院时73%达到mRS 0-3,长期随访82%达到mRS 0-3;死亡率8.3%,脑积水发生率36%。研究认为在资源有限环境下血管内治疗安全有效且持久。

要点

  • 血管内治疗aSAH后长期功能结局良好,82%达mRS 0-3。
  • 脑积水和术中并发症是死亡预测因素,无脑室内出血具保护作用。
  • 资源有限地区可安全开展血管内治疗,支持在非洲推广。

核心结论

  • 在资源有限环境下,血管内治疗aSAH安全、有效且持久,支持在非洲扩大应用。

研究设计与样本

  • 回顾性分析2012至2021年在南非Inkosi Albert Luthuli Central Hospital接受血管内治疗的445例aSAH患者。
  • 纳入标准为CT或腰穿证实的自发性aSAH及CT血管造影识别的囊状动脉瘤。

主要发现

  • 中位年龄47岁,67%为女性,75%为黑人非洲裔。
  • 81%为WFNS 1-3级,90%为前循环动脉瘤,中位大小5.7 mm。
  • 217例已知HIV状态者中48%为HIV携带者。
  • 出院时73%达mRS 0-3,84%达RROC 1;长期随访82%达mRS 0-3,90%达RROC 1。
  • 死亡率为8.3%,并发症包括脑积水36%、血管痉挛22%、脑膜炎10%。

关键数值与推荐

  • 死亡预测因素包括脑积水和术中并发症;无脑室内出血为保护因素。

临床怎么用

  • 在资源有限地区,血管内治疗可作为aSAH的有效治疗选择。
  • 应关注脑积水和术中并发症以降低死亡风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Aneurysmal subarachnoid hemorrhage (aSAH) is a severe stroke subtype with high morbidity and mortality, particularly in low- and middle-income countries. Endovascular treatment is underused in Africa due to resource constraints. This study evaluates clinical characteristics, radiological findings, treatment outcomes, and long-term follow-up of aSAH patients treated endovascularly at a South African quaternary hospital. METHODS: A retrospective analysis of 445 aSAH patients treated endovascularly at the Inkosi Albert Luthuli Central Hospital (2012-2021) was conducted. Inclusion criteria were spontaneous aSAH confirmed by computed tomography/lumbar puncture and saccular aneurysm identified via computed tomography angiogram. Data on demographics, clinical presentation, World Federation of Neurological Societies and Modified Fisher grades, aneurysm characteristics, treatments, complications, and outcomes (modified Rankin Scale [mRS] and Raymond-Roy Occlusion Classification [RROC]) were analyzed. Logistic regression identified predictors of mortality, hydrocephalus, and vasospasm. RESULTS: Median age was 47 years (67% female, 75% Black African). Most (81%) had World Federation of Neurological Societies grades 1-3; 90% had anterior circulation aneurysms (median size 5.7 mm). Of 217 patients with known human immunodeficiency virus status, 48% were living with human immunodeficiency virus. Coil embolization (59%) and balloon-assisted coiling at 21% were common. At discharge, 73% achieved mRS 0-3 and 84% RROC 1. Long-term, 82% had mRS 0-3 and 90% RROC 1. Mortality was 8.3%. Complications included hydrocephalus (36%), vasospasm (22%), and meningitis (10%). Predictors of mortality included hydrocephalus and intraoperative complications; absence of intraventricular hemorrhage was protective. CONCLUSIONS: This study, the largest in an African cohort, confirms safety, efficacy, and durability of endovascular management of aSAH in resource-constrained settings, supporting its expansion in Africa.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Harrichandparsad R, Bhigjee AI, Royston D, et al. Endovascular Management and Long-Term Outcomes of Aneurysmal Subarachnoid Hemorrhage Among a Large Cohort of Patients Managed at a Specialist Hospital in KwaZulu-Natal, South Africa from 2012 to 2021. World Neurosurg. 2025. PMID: 40818737. doi:10.1016/j.wneu.2025.124386

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。